ENDRA Life Sciences NDRA 深 滬
等待開盤 11-04 09:30:00 美东时间
4.86
+0.060
+1.25%
華盛通- 最 高4.945
- 今 開4.8302
- 成交量 3741股
- 最 低 4.745
- 昨 收 4.80
- 總市值 728.96万
- 52周最高 6.95
- 市盈率 靜 --
- 換手率 0.25%
- 52周最低 2.96
- 委 比 68.00%
- 總股本 149.99万
- 歷史最高 205800.00
- 量 比 0.41
- 振 幅 4.17%
- 歷史最低 2.90
- 每 手 1
- 風險率 0.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ASP Isotopes Inc. Announces that Renergen Limited’s Virginia Gas Project has Achieved Stable Liquid Helium Production
ASP Isotopes subsidiary Tetra4 has completed commissioning of its helium liquefaction plant, achieving stable liquid helium production. The Virginia Gas Project, South Africa's first onshore petroleum producer, is now accumulating helium in storage ahead of initial deliveries to contracted customers. Paul Mann highlighted this milestone as critical for addressing global helium supply pressures. The project is expected to reach full capacity by Q4...
10-26 12:00
ENDRA Life Sciences Amends Merger Agreement and Warrants
ENDRA Life Sciences ( ($NDRA) ) just unveiled an update. On October 1, 2026, EN...
10-02 05:51
ASP Isotopes Inc. Announces that Renergen Limited’s Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa
Tetra4, a subsidiary of Renergen, has initiated the commissioning phase of its Phase 1 Liquid Helium plant following engineering optimization, aiming to address the global helium shortage. The company expects to deliver liquid helium to customers by September 2026, ramping up production to full capacity by the second half of the year. With Phase 1 set to produce 2,500 GJ/day of LNG and 70 Mcf/day of liquid helium, Renergen anticipates generating ...
08-20 12:00
ENDRA Life Sciences Q2 EPS $0.06 Beats $(0.84) Estimate
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.84) by 107.14 percent. This is a 103.51 percent increase over losses of $(1.71) per share from the same period last year.
08-17 20:11
ASP Isotopes to Participate in Citi’s 2026 Natural Resources Conference
ASP Isotopes Inc. will host investor meetings at Citi's 2026 Natural Resources Conference on August 13, 2026, in Las Vegas. The company, focused on developing isotope enrichment technologies for critical materials in nuclear medicine, semiconductors, and energy, operates facilities in South Africa. ASP Isotopes is also involved in proposed transactions with ENDRA Life Sciences Inc., including a merger, with related materials to be filed with the ...
08-05 12:00
ASP Isotopes says PET Labs, Renergen, isotope facilities nearing key milestones
ASP Isotopes (ASPI) up 4.3% pre-market Tuesday after releasing a shareholder letter outlining operational progress across its business units ahead of Q2 financial results. ASP (ASPI) said PET Labs pos...
08-04 21:27
ASP Isotopes Issues Letter to Shareholders
ASP Isotopes Inc. reported strong progress across its business units, including 50% revenue growth in PET Labs, upcoming helium production at Renergen, and advancements in stable isotope enrichment. The company expects significant contributions to profitability from these divisions. Additionally, Renergen is set to become a Nasdaq-listed company through a reverse merger, and Quantum Leap Energy is pursuing a public listing. Alpa Theranostics is a...
08-04 12:00
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
<p>Noble Africa LLC, a subsidiary of ASP Isotopes Inc., will merge with a subsidiary of ENDRA Life Sciences Inc. in a transaction expected to create Noble Africa Inc., a Nasdaq-listed company focused on Renergen’s Virginia Gas helium project. The merger, along with a concurrent private placement targeting $50 million in gross proceeds, aims to provide capital and market access for project development. ASP Isotopes will own approximately 89% of th...
06-25 13:30
